CHICAGO, IL / ACCESS Newswire / February 5, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company")(NASDAQ:COSM) , a ...

Reports of anaphylaxis associated with the use of glatiramer acetate have prompted the Food and Drug Administration (FDA) to add a Boxed Warning to the prescribing information.

CHICAGO, IL / ACCESS Newswire / February 5, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company")(NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovativ ...

The exact cause of MS is unknown, but it is thought US, NY, UNITED STATES, January 31, 2025 /EINPresswire / -- Multiple Sclerosis Ms Drugs market industry Overview 2025 By Drug Class (Disease ...

Novartis on Friday posted adjusted net income well above analyst estimates as sales of established heart failure drug ...

A new FTC report found that pharmacy benefit managers have inflated the price of life-saving generic prescription drugs, finding the companies sometimes increased prices of these drugs by 1,000 ...

The next big advance in treating diseases like rheumatoid arthritis could be tiny pulses of electricity delivered to the ...

RHHBY records impressive sales growth in 2024 on the back of strong demand for Vabysmo, Hemlibra, Phesgo and Ocrevus.

As a judge in Washington, D.C., considers further halting the Trump administration's freeze on federal funds, a new court ...

Beta interferon should not be given to NHS patients with multiple sclerosis, the National Institute ... been pinning their hopes on obtaining the drug. In November, the final appraisal on the ...

February 10-11: BIO CEO & Investor Conference 2025. Daniel Vitt, Ph.D., Chief Executive Officer of Immunic, will participate in one-on-one meetings at this conference, taking place in New York.

Visit this Multiple Sclerosis Resource hub for helpful articles and information about MS. Here are some potential questions to ask. Other disease-modifying drugs exist on the market to reduce ...